agree. I’m big on looking at comparable trials to see how...

agree. I’m big on looking at comparable trials to see how recruitment went as that’s often a good guide to the scale of the challenge . Take MPACT panc cancer trial I referred to before (gemcitabine + abraxane) . The published study says it took about 3 years with 150 sites to get 860 patients. That’s about 2 patients per site per year. Unless you think there’s a reason why ACCENT can substantially outperform MPACT , then I’d be using that estimate as a guide.
If that plays out here, with 11 sites, then could take at least a year to get this 26….